Vor Biopharma Inc. (VOR) DCF Valuation

Vor Biopharma Inc. (VOR) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Vor Biopharma Inc. (VOR) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Whether you're an investor or analyst, this [Symbol] DCF Calculator is your go-to resource for accurate valuation. Loaded with real data from Vor Biopharma Inc., you can adjust forecasts and immediately observe the effects.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA -10.2 -42.0 -67.6 -90.9 -114.4 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .1 1.4 4.5 9.0 3.5 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -10.3 -43.3 -72.0 -99.9 -117.9 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 6.5 48.5 207.5 230.2 137.2 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .7 2.4 1.5 1.8 .8 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure -.7 -4.2 -3.9 -8.5 -1.1 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -10.8 -43.3 -71.9 -98.4 -117.9 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -10.8 -44.4 -72.2 -97.7 -116.4 -.8 .0 .0 .0 .0
WACC, % 5.12 5.12 5.11 5.1 5.12 5.11 5.11 5.11 5.11 5.11
PV UFCF
SUM PV UFCF -.8
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt 4
Equity Value -5
Diluted Shares Outstanding, MM 67
Equity Value Per Share -0.08

What You Will Get

  • Real VOR Financials: Access to historical and projected data for precise valuation.
  • Customizable Inputs: Adjust WACC, tax rates, revenue growth, and capital expenditures as needed.
  • Automatic Calculations: Intrinsic value and NPV are computed in real-time.
  • Scenario Analysis: Evaluate various scenarios to assess Vor Biopharma's future performance.
  • Clear and Intuitive Design: Designed for professionals while remaining user-friendly for newcomers.

Key Features

  • Customizable Research Parameters: Adjust essential inputs such as clinical trial success rates, market penetration, and R&D expenditures.
  • Instant Valuation Insights: Automatically computes intrinsic value, NPV, and other key metrics in real-time.
  • Industry-Leading Precision: Leverages Vor Biopharma's (VOR) actual financial data for credible valuation results.
  • Effortless Scenario Testing: Evaluate various assumptions and analyze results with ease.
  • Efficiency Booster: Streamline your analysis without the hassle of constructing intricate valuation models from the ground up.

How It Works

  • Step 1: Download the prebuilt Excel template featuring Vor Biopharma Inc.'s (VOR) data.
  • Step 2: Review the pre-filled sheets to familiarize yourself with the essential metrics.
  • Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
  • Step 4: Instantly see recalculated results, including Vor Biopharma Inc.'s (VOR) intrinsic value.
  • Step 5: Make well-informed investment decisions or create reports based on the outputs.

Why Choose Vor Biopharma's Calculator?

  • Precision: Leveraging real Vor Biopharma financials for reliable data.
  • Adaptability: Crafted for users to easily test and adjust inputs.
  • Efficiency: Eliminate the need to create a DCF model from the ground up.
  • Expert-Level: Designed with the accuracy and usability expected by CFOs.
  • Intuitive: Simple to navigate, even for those without extensive financial modeling skills.

Who Should Use This Product?

  • Biotech Students: Understand drug development processes and apply them using real-world examples.
  • Researchers: Integrate advanced biopharmaceutical models into your studies or publications.
  • Investors: Evaluate your investment strategies and assess the potential of Vor Biopharma Inc. (VOR).
  • Market Analysts: Optimize your analysis with a tailored, ready-to-use financial model for biopharma.
  • Healthcare Entrepreneurs: Discover how public biotech companies like Vor Biopharma Inc. (VOR) are evaluated in the market.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Vor Biopharma Inc. (VOR) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Vor Biopharma Inc. (VOR).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

Es wurden keine passenden Produkte gefunden.